Mindbio Therapeutics Corp (MBQIF)

$0.60 -0.01 (-1.64%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 1,000
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 69%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

MindBio Therapeutics Corp., together with its subsidiaries, engages in researching, developing, and testing psychedelic substances as a potential treatment for the management of various mental health conditions in Australasia. Its lead drug candidate is MB22001, a form of lysergic acid diethylamide in Phase 2A trials. The company also develops wearable devices to collect biometric data in mental health patients taking psychedelic medicines; and invests in research that forms the basis for develo...

Address:
1055 West Georgia Street, 1500 Royal Centre P.O Box 11117, Vancouver, Canada
JTE_Theta
JTE_Theta Mar. 5 at 4:12 PM
Disseminated on behalf of MindBio Therapeutics (CSE: $MBIO) (OTCQB: $MBQIF) AI Voice Tech Turning Human Speech Into Real Time Risk Signals 🧬 With 50M+ voice data points, their platform detects cognitive & physiological biomarkers from short voice samples ! No hardware, No wearables, No invasive testing. CommunicatedDisclaimer: http://tinyurl.com/54jmx7k9
1 · Reply
JTE_Theta
JTE_Theta Mar. 4 at 1:51 AM
🧠The Mental Health Market Is Broken. $MBIO / $MBQIF Is Building Something Different. Traditional antidepressants can take weeks to work, often come with heavy side effects, and don’t help everyone. MindBio Therapeutics Corp is developing regulated, take-home psychedelic microdosing therapies designed for scalable treatment of depression, anxiety, PTSD, and cancer related distress. Their lead program, MB22001, is currently in Phase 2 clinical development -Ttargeting structured protocols that could move psychedelic therapy beyond clinics and into accessible, real world care. Why this is interesting 🧠 • Focus on regulated take home model vs in clinic only treatments • Late stage clinical progress in a rapidly emerging sector • Integration of AI health monitoring tech for data + safety • Exposure to a multi billion dollar global mental health opportunity CommunicatedDisclaimer:http://tinyurl.com/4sahjja4
1 · Reply
griffinrc23
griffinrc23 Feb. 25 at 1:59 PM
MindBio Therapeutics Corp. ($MBQIF) is a clinical-stage biopharmaceutical company specializing in innovative treatments for mental health conditions and AI-driven impairment detection technologies. https://mindbiotherapeutics.com/
0 · Reply
Latest News on MBQIF
No data available.
JTE_Theta
JTE_Theta Mar. 5 at 4:12 PM
Disseminated on behalf of MindBio Therapeutics (CSE: $MBIO) (OTCQB: $MBQIF) AI Voice Tech Turning Human Speech Into Real Time Risk Signals 🧬 With 50M+ voice data points, their platform detects cognitive & physiological biomarkers from short voice samples ! No hardware, No wearables, No invasive testing. CommunicatedDisclaimer: http://tinyurl.com/54jmx7k9
1 · Reply
JTE_Theta
JTE_Theta Mar. 4 at 1:51 AM
🧠The Mental Health Market Is Broken. $MBIO / $MBQIF Is Building Something Different. Traditional antidepressants can take weeks to work, often come with heavy side effects, and don’t help everyone. MindBio Therapeutics Corp is developing regulated, take-home psychedelic microdosing therapies designed for scalable treatment of depression, anxiety, PTSD, and cancer related distress. Their lead program, MB22001, is currently in Phase 2 clinical development -Ttargeting structured protocols that could move psychedelic therapy beyond clinics and into accessible, real world care. Why this is interesting 🧠 • Focus on regulated take home model vs in clinic only treatments • Late stage clinical progress in a rapidly emerging sector • Integration of AI health monitoring tech for data + safety • Exposure to a multi billion dollar global mental health opportunity CommunicatedDisclaimer:http://tinyurl.com/4sahjja4
1 · Reply
griffinrc23
griffinrc23 Feb. 25 at 1:59 PM
MindBio Therapeutics Corp. ($MBQIF) is a clinical-stage biopharmaceutical company specializing in innovative treatments for mental health conditions and AI-driven impairment detection technologies. https://mindbiotherapeutics.com/
0 · Reply